ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice.

scientific article published in December 2006

ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1031613871
P356DOI10.1080/13550280601009546
P698PubMed publication ID17162658

P50authorJavier S. BurgosQ45402352
Esther Serrano-SaizQ79427128
P2093author name stringFernando Valdivieso
Isabel Sastre
P2860cites workElectrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applicationsQ24561689
Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47Q24562414
Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of miceQ24817190
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Selectivity of MHC-encoded peptide transporters from human, mouse and ratQ28249591
A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathwayQ28266815
TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cellsQ28589574
Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by genderQ33717104
Construction and properties of a viable herpes simplex virus 1 recombinant lacking coding sequences of the alpha 47 geneQ33929730
TAP deficiency syndromeQ33994458
Herpes simplex virus type 1, apolipoprotein E and Alzheimer' diseaseQ34342133
Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous systemQ34360596
Hematogenous vertical transmission of herpes simplex virus type 1 in miceQ34435095
Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigenQ34754320
Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses.Q34840276
Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAPQ35899978
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAININGQ36266931
Peptide length and sequence specificity of the mouse TAP1/TAP2 translocatorQ36362717
The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residuesQ36377189
Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response.Q36400254
Antigen recognition by class I-restricted T lymphocytesQ38201551
Abeta production as consequence of cellular death of a human neuroblastoma overexpressing APP.Q40536280
Neonatal herpes simplex infection in the absence of mucocutaneous lesionsQ40844864
Peptides naturally presented by MHC class I moleculesQ40898177
Herpes simplex virus turns off the TAP to evade host immunityQ41338579
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytesQ41467257
HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2.Q41480540
Herpes simplex virus latent infection in the nervous systemQ41530799
Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infection.Q43996344
Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridineQ44460660
A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers.Q45021493
ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1.Q45710894
Neurotropic viruses and Alzheimer disease. Interaction of herpes simplex type 1 virus and apolipoprotein E in the etiology of the diseaseQ45767261
Histological study of the progression of herpes simplex virus in miceQ45803614
Herpes-simplex-virus infection after renal transplantationQ45825855
Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer typeQ45877119
A viral inhibitor of peptide transporters for antigen presentationQ46243412
Influence of reagents formulation on real-time PCR parametersQ77068230
P433issue6
P921main subjectHerpes simplex virus type 1Q655331
P304page(s)420-427
P577publication date2006-12-01
P1433published inJournal of NeuroVirologyQ6295640
P1476titleICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus type 1 in mice
P478volume12

Reverse relations

cites work (P2860)
Q38933333An MHC class I immune evasion gene of Marek׳s disease virus.
Q35040097Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice
Q35172570Effects of thyroid hormone on HSV-1 gene regulation: implications in the control of viral latency and reactivation.
Q34628398Genome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinology
Q37253362HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion
Q37135532Immunological control of herpes simplex virus infections
Q28083232Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution